Last update :
08/05/2024
Antifungal   Amphotericin B cholesteryl sulfate complex  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amphotec Austria, Great Britain, Greece, Poland, Slovenia, Turkey, United States of America
References   Injection   References : Amphotericin B cholesteryl sulfate complex  
Type Publication
921 Journal Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1407 Journal Xu QA, Trissel LA, Gilbert DL.
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Hosp Pharm 1998 ; 33: 1203-1207.
1982 Journal Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262 Journal Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3578 Manufacturer Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644 Manufacturer Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010

  Mentions Légales